论文部分内容阅读
目的探讨尿微量白蛋白测定在早期糖尿病肾病中的应用价值。方法选取35例2型糖尿病患者作为观察组,同时选取同期健康体检的35例健康人作为对照组,两组均进行尿微量白蛋白测定,比较两组的测定结果。结果两组尿微量白蛋白定量检测结果及检测阳性率比较差异具有统计学意义(P<0.05);且观察组中不同病程患者尿微量白蛋白检测阳性率比较差异具有统计学意义(P<0.05),随着病程的延长患者尿微量白蛋白检测阳性率显著增加。结论尿微量白蛋白检测在早期糖尿病肾病诊断中有着非常重要的作用,其对指导临床治疗、评估患者病情、改善患者预后方面有着不容忽视的作用,可在临床上推广应用。
Objective To investigate the value of urinary microalbuminuria in early diabetic nephropathy. Methods 35 cases of type 2 diabetes mellitus were selected as the observation group, and 35 healthy people in the same period were selected as the control group. Urinary microalbumin was measured in both groups, and the results of the two groups were compared. Results The positive rate of urinary microalbuminuria in both groups was statistically significant (P <0.05), and the positive rate of urine microalbuminuria in the observation group was statistically significant (P <0.05 ), With the extension of the duration of patients with urine microalbumin detection positive rate increased significantly. Conclusion Urinary microalbuminuria has a very important role in the early diagnosis of diabetic nephropathy. It plays an important role in guiding the clinical treatment, assessing the patient’s condition and improving the prognosis of patients. It can be widely applied in clinical practice.